Already in 2011, Bignotti et al. suggested that the HE4 concentration, alone or in combination with the concentration of CA125, could predict the prognosis of patients with endometrial cancer (as in patients with lung adenocarcinoma or epithelial ovarian cancer) [30]. This evidence concerns the gene WFDC2 and endometrial cancer.